We are live on
!
Find out more
EAM
EULAV Asset Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
23.04%
This Fund
S&P 500
This Quarter
Est. Return
-16.14%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.42B
AUM Growth
-$937M
(-28%)
Cap. Flow
-$375M
Cap. Flow
% of AUM
-15.49%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
229
New
12
Increased
31
Reduced
91
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$11.2M |
| 2 |
Booking.com
BKNG
|
+$10.2M |
| 3 |
Intercontinental Exchange
ICE
|
+$8.76M |
| 4 |
Devon Energy
DVN
|
+$8.49M |
| 5 |
Cintas
CTAS
|
+$8.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$41.7M |
| 2 |
Roper Technologies
ROP
|
+$26.1M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$21.9M |
| 4 |
Rollins
ROL
|
+$17.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.41% |
| 2 | Industrials | 16.87% |
| 3 | Financials | 15.68% |
| 4 | Healthcare | 15.08% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Blackstone
BX
$102B
| $8.85M | 0.37% |
97,000
-15,000
| -13% | -$1.62M |
|
77
Okta
OKTA
$24.4B
| $8.68M | 0.36% |
96,000
+36,000
| +60% | +$3.89M |
|
78
Woodward
WWD
$21.2B
| $8.6M | 0.36% |
93,000
-9,000
| -9% | -$937K |
|
79
US Physical Therapy
USPH
$1.22B
| $8.5M | 0.35% |
77,800
| – | – |
|
|
80
Booking.com
BKNG
$150B
| $8.4M | 0.35% |
+120,025
| New | +$10.2M |
|
81
DexCom
DXCM
$28.8B
| $8.35M | 0.34% |
112,000
+36,000
| +47% | +$3.29M |
|
82
HEICO Corp
HEI
$49.5B
| $8.34M | 0.34% |
63,583
-45,333
| -42% | -$6.39M |
|
83
Monolithic Power Systems
MPWR
$64.7B
| $8.28M | 0.34% |
21,569
| – | – |
|
84
First Financial Bankshares
FFIN
$5B
| $8.11M | 0.33% |
206,496
| – | – |
|
85
Ulta Beauty
ULTA
$22.2B
| $8.1M | 0.33% |
21,002
-8,999
| -30% | -$3.58M |
|
86
CrowdStrike
CRWD
$189B
| $8.09M | 0.33% |
192,000
-28,000
| -13% | -$1.27M |
|
|
87
Rollins
ROL
$18.5B
| $8.07M | 0.33% |
231,049
-520,873
| -69% | -$17.9M |
|
88
Verisk Analytics
VRSK
$26.1B
| $7.89M | 0.33% |
45,600
| – | – |
|
89
FIVE9
FIVN
$2.12B
| $7.65M | 0.32% |
83,900
| – | – |
|
90
Roku
ROKU
$21.5B
| $7.47M | 0.31% |
91,000
+13,000
| +17% | +$1.26M |
|
91
Twilio
TWLO
$29B
| $7.38M | 0.3% |
88,000
+23,000
| +35% | +$2.57M |
|
|
92
Devon Energy
DVN
$50.9B
| $7.16M | 0.3% |
+130,000
| New | +$8.49M |
|
93
Alibaba
BABA
$279B
| $7.16M | 0.3% |
63,000
+2,000
| +3% | +$196K |
|
94
Motorola Solutions
MSI
$71.5B
| $7.15M | 0.29% |
34,100
| – | – |
|
95
Silgan Holdings
SLGN
$4.34B
| $7.14M | 0.29% |
172,600
-18,000
| -9% | -$791K |
|
|
SPLK
96
DELISTED
Splunk Inc
SPLK
| $7.08M | 0.29% |
80,000
-13,000
| -14% | -$1.43M |
|
97
Cooper Companies
COO
$14.2B
| $6.92M | 0.29% |
88,400
-10,400
| -11% | -$920K |
|
98
lululemon athletica
LULU
$13.6B
| $6.82M | 0.28% |
+25,000
| New | +$8.01M |
|
99
Aaon
AAON
$7.17B
| $6.78M | 0.28% |
185,621
| – | – |
|
100
Bio-Rad Laboratories Class A
BIO
$8.74B
| $6.73M | 0.28% |
13,600
| – | – |
|
Similar funds
LFG
BI
GKWIM
DIG
BP
CCI
PC
TCG
EULAV Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, EULAV Asset Management held 229 positions worth $2.42B, down 28% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
EULAV Asset Management withdrew a net $375M in Q2 2022, closing 27 positions and reducing 91 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $21.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Industrials and Financials.
Against the trend, EULAV Asset Management opened a new position in Advanced Micro Devices worth $9.18M.
- EULAV Asset Management's largest Q2 2022 buy was Advanced Micro Devices: 120,043 shares worth $9.18M.
- EULAV Asset Management added most to Intercontinental Exchange in Q2 2022, an estimated $8.76M increase.
- EULAV Asset Management's biggest Q2 2022 reduction was Mastercard, cutting an estimated $41.7M.
- EULAV Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $21.9M.
- EULAV Asset Management's ten largest holdings make up 22% of its $2.42B portfolio in Q2 2022.
- EULAV Asset Management opened 12 new positions and closed 27 in Q2 2022.
- EULAV Asset Management's portfolio value fell 28% quarter-over-quarter to $2.42B.
Based on EULAV Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.